PLSE May 2024 5.000 call
| Previous Close | 2.5300 |
| Open | 2.7500 |
| Bid | 2.3500 |
| Ask | 5.5000 |
| Strike | 5.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 2.7500 - 2.8000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 145 |
Business WirePulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
HAYWARD, Calif., May 16, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced CellFX nsPFA technology will be featured in multiple presentations at the upcoming Heart Rhythm Society (HRS) 2024 Annual Meeting in Boston, MA from May 16-19.
Business WirePulse Biosciences Enhances Executive Leadership Team
HAYWARD, Calif., May 14, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology ("Pulse"), today announced enhancements to its executive leadership team to support its next pivotal phase of growth.
Insider MonkeyPulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript May 11, 2024 Pulse Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Pulse Biosciences First Quarter 2024 Financial Results Conference Call. At this time, […]
